NASDAQ · MLEC
Healthcare · Biotechnology
$0.85
Down-$0.55 (-39.29%)
Updated Nov 5, 2026, 2:02 AM
SID Score
3.5/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance · MLEC
1M range · 19 trading sessions · Daily adjusted prices
Prices through Nov 2, 2026
MLEC closed at $0.85 after 19 trading sessions, down 82.33% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 2, 2026 | $1.40 | $1.54 | $0.80 | $0.85 | 273.28K |
| Oct 30, 2026 | $1.38 | $1.42 | $1.35 | $1.40 | 7.26K |
| Oct 29, 2026 | $1.54 | $1.54 | $1.35 | $1.37 | 14.2K |
| Oct 28, 2026 | $1.55 | $1.58 | $1.46 | $1.51 | 24.62K |
| Oct 27, 2026 | $1.56 | $1.63 | $1.46 | $1.47 | 26.51K |
| Oct 26, 2026 | $1.72 | $1.72 | $1.34 | $1.52 | 24.81K |
| Oct 23, 2026 | $1.65 | $1.74 | $1.605 | $1.72 | 8.26K |
| Oct 22, 2026 | $1.69 | $1.80 | $1.52 | $1.685 | 56.43K |
| Oct 21, 2026 | $1.655 | $1.7106 | $1.63 | $1.67 | 22.01K |
| Oct 20, 2026 | $1.50 | $1.80 | $1.50 | $1.60 | 34.44K |
| Oct 19, 2026 | $1.61 | $1.67 | $1.481 | $1.535 | 28.66K |
| Oct 16, 2026 | $1.72 | $1.88 | $1.50 | $1.68 | 97.74K |
| Oct 15, 2026 | $1.93 | $2.76 | $1.50 | $1.87 | 754.17K |
| Oct 14, 2026 | $1.69 | $2.02 | $1.62 | $1.87 | 119.64K |
| Oct 13, 2026 | $1.82 | $1.82 | $1.64 | $1.709 | 45.51K |
| Oct 12, 2026 | $1.69 | $2.50 | $1.69 | $1.80 | 160.64K |
| Oct 9, 2026 | $4.42 | $4.42 | $1.99 | $2.20 | 176.68K |
| Oct 8, 2026 | $4.695 | $4.825 | $4.19 | $4.19 | 10.85K |
| Oct 7, 2026 | $4.82 | $4.82 | $4.80 | $4.81 | 1.23K |
The latest Smart Investors Daily articles mentioning MLEC.
Company
Market Activity
Research & News
MLEC research
Company profile and research snapshot.
Moolec Science SA is a science-based ingredient company focused on producing real animal proteins in plants through Molecular Farming, a technology in the alternative protein landscape. Its purpose is to upgrade the taste, nutrition, and affordability of alternative protein products while building a more sustainable and equitable food system. The company has various products in its pipeline such as; TSP Valorasoy which is a soy protein product to produce vegetable proteins with texture and fibrousness similar to those of meat, Glaso, a safflower oil with high levels of gamma-linolenic acid, SPC2 which is a plant-based chymosin, YEEA1, an extract derived from a novel yeast biomass with specific properties, and others. The company's revenues arise from operations in Argentina.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Jan 30, 2024 | Maxim Group | Buy | — |
No generated briefing is available yet.
Benzinga · Aug 17, 2026
Gainers IP Strategy Holdings (NASDAQ:IPST) shares rose 13.2% to $8.37 during Monday's after-market session. The company's market cap stands at $1.5 million. Splash Beverage Group (AMEX:SBEV) stock rose 5.82%
Finnhub · May 14, 2026
WARWICK, GB / ACCESS Newswire / May 14, 2026 / Moolec Science Limited, a wholly owned subsidiary of Moolec Science SA , an innovation-driven company engineering plants and microbes to unlock scalable...
Benzinga · May 1, 2026
Benzinga · Feb 24, 2026
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning MLEC.
No results
No recent SID articles mention MLEC.
